Immucell (ICCC) Free Cash Flow (QoQ) (2010 - 2025)
Powered by 
Analysis
Immucell (ICCC) Free Cash Flow (QoQ) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 117.46% |
| Sep 30, 2025 | -222.83% |
| Jun 30, 2025 | 16.19% |
| Mar 31, 2025 | 724.68% |
| Dec 31, 2024 | 72.62% |
| Sep 30, 2024 | -254.50% |
| Jun 30, 2024 | 35.30% |
| Mar 31, 2024 | 143.28% |
| Dec 31, 2023 | 13.34% |
| Sep 30, 2023 | 33.21% |
| Jun 30, 2023 | 59.64% |
| Mar 31, 2023 | -23.53% |
| Dec 31, 2022 | -39.94% |
| Sep 30, 2022 | -249.64% |
| Jun 30, 2022 | -237.26% |
| Mar 31, 2022 | -44.78% |
| Dec 31, 2021 | 71.97% |
| Sep 30, 2021 | -180.40% |
| Jun 30, 2021 | 84.74% |
| Mar 31, 2021 | -657.50% |